T CELL PHENOTYPES ASSOCIATED WITH RESPONSE TO ADOPTIVE CELL THERAPY
Japan
2023-515322
Filed on 2023-03-07
2023-515322
Filed on 2023-03-07
PREFERENTIAL GENERATION OF iPSC CARRYING ANTIGEN SPECIFIC TCRs FROM TUMOR INFILTRATING LYMPHOCYTES
European Patent
21769306.8
Filed on 2023-03-08
21769306.8
Filed on 2023-03-08
PREFERENTIAL GENERATION OF iPSC CARRYING ANTIGEN SPECIFIC TCRs FROM TUMOR INFILTRATING LYMPHOCYTES
US Application 18/020,823
Filed on 2023-02-10
Filed on 2023-02-10
PREFERENTIAL GENERATION OF iPSC CARRYING ANTIGEN SPECIFIC TCRs FROM TUMOR INFILTRATING LYMPHOCYTES
Japan
2023-512482
Filed on 2023-02-20
2023-512482
Filed on 2023-02-20
HUMAN IMMUNOGENIC EPITOPES OF HEMO and HHLA2 HUMAN ENDOGENOUS RETROVIRUSES (HERVS)
Hong Kong
62023070659.5
Filed on 2023-03-27
62023070659.5
Filed on 2023-03-27
Anti-Human Papillomavirus 16 E7 T Cell Receptors
Australia
2023200608
Filed on 2023-02-06
2023200608
Filed on 2023-02-06
COMBINATION IMMUNOTHERAPY FOR TREATING CANCER
Patent Cooperation Treaty
PCT/US2023/062288
Filed on 2023-02-09
PCT/US2023/062288
Filed on 2023-02-09
LZK-TARGETING DEGRADERS AND METHODS OF USE
European Patent
21790644.5
Filed on 2023-03-29
21790644.5
Filed on 2023-03-29
LZK-TARGETING DEGRADERS AND METHODS OF USE
US Application 18/176,849
Filed on 2023-03-01
Filed on 2023-03-01
LZK-TARGETING DEGRADERS AND METHODS OF USE
Australia
2021336300
Filed on 2023-02-15
2021336300
Filed on 2023-02-15